Vitalii Kovalchuk was born in Vilnius (Lithuania) in 1967. Professor Vitalii Kovalchuk is the Head of Department of Neurological Rehabilitation and the Head of Medical Rehabilitation Centre. V. Kovalchuk had graduated Pavlov's St.-Petersburg Medical University, passed scientific and practical training in Germany (Saarland University, Medical Faculty, Homburg-Saar) and in UK (Universities and clinics of London, Edinburgh, Newcastle). His research and practical areas including the rehabilitation of patients with damage of brain (stroke, drain injury and so on), chronic brain ischemia, pain syndromes, cognitive and psychoemotional impairments, and has published widely in these fields and has lectures and master-classes at different region and countries all over the World. V. Kovalchuk is the author of more than 260 published scientific articles and 17 monographs. V. Kovalchuk is the member of a lot of the Editorial Boards of different world’s Journal: “American Journal of Psychiatry and Neuroscience”, “Neuropsychiatric Disease and Treatment” (United Kingdom), “International Journal of Science, Technology and Society”, “PiscoMed Publishing Pte. Ltd.” (Singapore) and many others. Prof. V. Kovalchuk is a leading lecturer of the project "School of NeuroRehabilitation," which conducts educational seminars, master classes, conferences in various regions and cities of Russia, Spain, Kazakhstan, Belarus, Greece, the Czech Republic, Slovakia, Italy, Uzbekistan and other countries. Prof. V. Kovalchuk is working as a visiting professor and leading of master classes and lectures in different Universities and medical and preventive Institutions of various countries (United Arab Emirates, Kuwait, Lebanon, Namibia, Angola, Australia, Kazakhstan, Uzbekistan, Japan, Singapore and others). Career: resident of Pavlov's St.-Petersburg Medical University (Neurological Department, 1993-1995); researcher (Neurological Department, 1995-1997); associated professor of Medical Faculty of St.-Petersburg University (2008-2011); Honorary Doctorate of Letters (since 2013), Vice-President of World Congress of Arts, Sciences and Communications (since 2015). Career Related: Fellow of Stroke Association of UK (since 1998); Chairman of St.-Petersburg's Society of Rehabilitation (since 2008); Adjunct Professor of Neurological Association of Russian's NorthWest Region (since 2009); Adjunct Professor of European Academy of Natural Sciences (since 2012); Adjunct Professor of Cambridge University (since 2014); Fellow of Presidium of St.-Petersburg's Neurological Association (since 2016); Member of the UN Honorary List "the 500 great leaders of opinion of the world " (since 2016) Awards: Best Researcher of Year, 2011 (Academy of Medical Science, Russia); Best Doctor of Russian Federation (Ministry of Health 2011); Best Doctor of the World (2011); Lifetime Achievement Award of World Congress of Arts, Sciences and Communications (2012); Great Minds of the 21st Century Award (ABI – 2012); Hall of Fame Award (IBC – 2012); World Lifetime Achievement Award (ABI – 2012); American Hall of Fame Award (ABC – 2012); Honoured Scientist of Europe (European Academy of Natural Sciences – 2012); Albert Schweitzer Medal Award for Humanism and Service to the People (European Academy of Natural Sciences – 2012); Max Joseph Pettenkofer's Medal Award for outstanding achievements and merits in the field of medical researches (European Academy of Natural Sciences – 2014); Honoured Doctor of Russia (2015).

Dr. Hua’s research has centered on the development and application of novel MRI technologies for in vivo functional and physiological imaging in the brain. These include the development of human and animal MRI methods to measure functional brain activities, cerebral perfusion and oxygen metabolism at high (3 Tesla) and ultra-high (7 Tesla and above) magnetic fields. He is particularly interested in novel MRI approaches to image small blood and lymphatic vessels in the brain. Collaborating with clinical investigators, these techniques have been applied to detect functional, vascular and metabolic abnormalities in the brain in neurodegenerative diseases.

Dr Rui Lin (MD. Ph.D) now is a Professor of epidemiology of School of Public Health and Center for Genomic and Personalized Medicine, Guangxi Medical University, China. She studied in Karolinska Institute, Sweden on cancer epidemiology as a visiting scholar in 2006-2007, and got her Ph.D in genetic epidemiology at University of Tasmania, Australia in 2014. She awarded Australian Endeavour International Postgraduate Research Scholarship (EIPRS) and the Hundred Talents Program of Higher Education Institution of Guangxi Province, China. She is the member of the American Nutrition Society and the first council of the Chinese Medicine Health Products Professional Committee of the World Federation of Chinese Medicine Societies, and the editor of Applied Preventive Medicine, and the reviewer of Critical Reviews in Food Science and Nutrition, iMeta, Gut Microbes, etc. Dr. Rui Lin is the PI of three National Natural Science Foundation of China projects and four of provincial and ministerial level projects. Recently she has published 11 SCI papers as the first author/corresponding author in Diabetologia (2022), European J of Nutrition (2022), Chemosphere (2021), JNNP (2014), etc. Her researches currently focus on nutrition, genetic epidemiology and microbiome of type 2 diabetes.

Her research topic mainly focuses on the influencing factors of children’s growth and development, and how environmental chemicals contributed to the risk of cardiovascular complications during childhood, and has expanded her interest to the role of metabolomics and genomics in child cardiovascular health. To date, over 10 SCI papers have been published, with 9 of them being published as the first author. Additionally, she has actively contributed to the publication of several reports and books, participated in conference discussions and served as a course assistant for multiple times. In 2022, she received the Academic Innovation Award from Peking University. The topic reported at this conference is: “Exposure to Exogenous Phthalates combined with abnormal Endogenous Sex Hormones associated with Early Pubertal Onset among Children: a 3.5-year Longitudinal Cohort Study”.